Publications by authors named "L Roggero"
: We sought to investigate whether the 2012 Briganti nomogram may represent a potential prognostic factor of prostate cancer (PCa) progression after surgical treatment beyond European Association of Urology (EAU) risk categories. : From January 2013 to December 2021, data on PCa patients treated with robot-assisted radical prostatectomy at a single tertiary referral center were extracted. The 2012 version of the Briganti nomogram assessing the risk of pelvic lymph node invasion was used.
View Article and Find Full Text PDFObjective: To assess whether tumor location at diagnostic TURBT is predictive of ipsilateral nodal involvement in patients who underwent radical cystectomy (RC) with lymph-nodes dissection for bladder cancer (BCa).
Materials And Methods: All patients who underwent RC for BCa at a single institution between 2014-2023 were assessed. Tumor location at TURBT was defined as right-sided, median-line, left-sided, and diffused.
Objectives: We tested whether the 2012 Briganti nomogram for the risk of pelvic lymph node invasion (PLNI) may represent a predictor of disease progression after surgical management in high-risk (HR) prostate cancer (PCa) patients according to the European Association of Urology.
Methods: Between January 2013 and December 2021, HR PCa patients treated with robot-assisted radical prostatectomy (RARP) and extended pelvic lymph node dissection (ePLND) were identified. The 2012 Briganti nomogram was evaluated as a continuous and categorical variable, which was dichotomized using the median.
Outcomes of da Vinci® versus Hugo RAS® radical prostatectomy: focus on postoperative course, pathological findings, and patients' health-related quality of life after 100 consecutive cases (the COMPAR-P prospective trial).
Minerva Urol Nephrol
October 2024
Article Synopsis
- This study prospectively compares outcomes of robot-assisted radical prostatectomy (RARP) using two systems: Hugo RAS and da Vinci Xi, focusing on postoperative recovery, pathology, and quality of life.
- Conducted as the COMPAR-P trial, it involved 100 patients, with 50 undergoing each type of surgery performed by experienced surgeons using standardized techniques.
- Results showed no significant differences in postoperative complications or quality of life between the groups, but the study suggests the need for larger and more varied research to confirm findings and enhance clinical understanding.